Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

48.95
+1.042.17%
Post-market: 49.400.4500+0.92%17:03 EDT
Volume:3.66M
Turnover:179.39M
Market Cap:6.03B
PE:13.02
High:49.70
Open:47.74
Low:47.74
Close:47.91
Loading ...

These 4 Stocks Boast Impressive Interest Coverage Ratios

Zacks
·
06 Jan

Exploring 3 Prominent High Growth Tech Stocks In The United States

Simply Wall St.
·
01 Jan

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Zacks
·
30 Dec 2024

Halozyme Therapeutics Price Target Maintained With a $68.00/Share by HC Wainwright & Co.

Dow Jones
·
30 Dec 2024

Halozyme Announces Takeda Received Regulatory Approval for Hyqvia® 10% Subcutaneous Injection Set With Enhanze® in Japan for Patients With Agammaglobulinemia or Hypogammaglobulinemia

THOMSON REUTERS
·
30 Dec 2024

Halozyme reports FDA approval for Opdivo co-formulated with Enhanze

TIPRANKS
·
30 Dec 2024

Halozyme Announces argenx's Vydura With Enhanze® Was Granted Regulatory Approval in Japan for Chronic Inflammatory Demyelinating Polyneuropathy

THOMSON REUTERS
·
30 Dec 2024

Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig™ With Enhanze® for Subcutaneous Use in Most Previously Approved Adult Solid Tumor Opdivo® (Nivolumab) Indications

THOMSON REUTERS
·
30 Dec 2024

Market Today: Taiwan Cuts Tech Funding, China Counters US Firms

GuruFocus
·
28 Dec 2024

US FDA approves injectable form of Bristol Myers' Opdivo

Reuters
·
28 Dec 2024

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks
·
25 Dec 2024

3 Reasons Growth Investors Will Love Halozyme Therapeutics (HALO)

Zacks
·
24 Dec 2024

HALO or FOLD: Which Is the Better Value Stock Right Now?

Zacks
·
24 Dec 2024

U.S. RESEARCH ROUNDUP-Hershey, Paychex, Revvity

Reuters
·
23 Dec 2024

Halozyme Therapeutics Inc : JP Morgan Raises Target Price to $55 From $54

THOMSON REUTERS
·
23 Dec 2024

Halozyme Therapeutics Price Target Maintained With a $68.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Dec 2024

How Much Upside is Left in Halozyme Therapeutics (HALO)? Wall Street Analysts Think 27.08%

Zacks
·
16 Dec 2024

If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now

Zacks
·
16 Dec 2024

Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy?

Zacks
·
11 Dec 2024

Editas Stock Rises on Updated Data From SCD Study of Reni-Cel

Zacks
·
11 Dec 2024